Dual Trigger Versus Booster Dose of HCG

• Status: Completed
• Trial end date: 2018-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared dual trigger with GnRH agonist plus 1000 IU of HCG or triggering with GnRH and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Collaborators: Adam International Hospital; Nile Ivf Center, Cairo, Egypt
• Treatments: Chorionic Gonadotropin; Deslorelin

Criteria

Inclusion Criteria:

• High responder females undergoing antagonist protocol IVF/ICSI cycle

• More than 14 MII oocytes

• Estradiol more than 3500 pg/ml on day of trigger

Exclusion Criteria:

• Any other protocol

• Normal or poor responders